Cargando…
Induced pluripotent stem cell-derived lung alveolar epithelial type II cells reduce damage in bleomycin-induced lung fibrosis
BACKGROUND: Idiopathic pulmonary fibrosis is a chronic, progressive, and severe disease with a limited response to currently available therapies. Epithelial cell injury and failure of appropriate healing or regeneration are central to the pathogenesis of idiopathic pulmonary fibrosis. The purpose of...
Autores principales: | Alvarez-Palomo, Belén, Sanchez-Lopez, Luis Ignacio, Moodley, Yuben, Edel, Michael J., Serrano-Mollar, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268474/ https://www.ncbi.nlm.nih.gov/pubmed/32493487 http://dx.doi.org/10.1186/s13287-020-01726-3 |
Ejemplares similares
-
Improved Alveolar Dynamics and Structure After Alveolar Epithelial Type II Cell Transplantation in Bleomycin Induced Lung Fibrosis
por: Lopez-Rodriguez, Elena, et al.
Publicado: (2021) -
The Regenerative Power of Stem Cells: Treating Bleomycin-Induced Lung Fibrosis
por: Vats, Amrita, et al.
Publicado: (2023) -
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
por: Mehdizadeh, Saber, et al.
Publicado: (2022) -
T regulatory cells and attenuated bleomycin-induced fibrosis in lungs of CCR7(-/- )mice
por: Trujillo, Glenda, et al.
Publicado: (2010) -
Depletion of club cells attenuates bleomycin-induced lung injury and fibrosis in mice
por: Yokoyama, Tetsuya, et al.
Publicado: (2017)